Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FRG1CP is a human pseudogene classified as "FSHD region gene 1 family member C, pseudogene." It shares sequence similarity with protein-coding members of the FRG1 gene family, but there is no evidence that FRG1CP encodes a functional protein product. Pseudogenes like FRG1CP may be remnants of duplicated genes or evolutionary gene loss, and generally do not have active biological functions or roles as drug targets. The protein-coding gene family member, FRG1, is an actin-bundling protein involved in mRNA processing and muscle biology, and is linked to facioscapulohumeral muscular dystrophy, but FRG1CP itself is not implicated in disease or therapy[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FSHD region gene 1 family member C, pseudogene (FRG1CP).